Viewing StudyNCT06427213

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-06-16 @ 11:48 AM
Last Modification Date: 2024-10-26 @ 3:30 PM
Study NCT ID: NCT06427213
Status: NOT_YET_RECRUITING
Last Update Posted: 2024-05-23
First Post: 2024-05-19
Brief Title: This is a Phase II Open-label Multicentre Study of Zanubrutinib-containing Regimens in Patients With Newly Diagnosed Mantle Cell Lymphoma
Sponsor: Henan Cancer Hospital
Organization: Henan Cancer Hospital
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Lymphoma Non-Hodgkin
Lymphoma Mantle-Cell
Keywords:
Name View
Zanubrutinib View